Endophthalmitis.
Bohigian
George M
GM
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001372:Aza Compounds / Q000627:therapeutic use*; D001419:Bacteria / Q000302:isolation & purification; D009877:Endophthalmitis / Q000382:microbiology* / Q000517:prevention & control; D015818:Eye Infections, Bacterial / Q000382:microbiology* / Q000517:prevention & control; D024841:Fluoroquinolones / Q000627:therapeutic use*; D000077734:Gatifloxacin; D006801:Humans; D000077266:Moxifloxacin; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D018918:Phacoemulsification; D011183:Postoperative Complications; D011804:Quinolines / Q000627:therapeutic use*; D014822:Vitreous Body / Q000382:microbiology
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009883:Ophthalmic Solutions; D011804:Quinolines; D000077734:Gatifloxacin; D000077266:Moxifloxacin